Navigation Links
Joint HHC/GHX Project Earns Honors in Supply & Demand Chain Executive's 2011 Executive 100
Date:5/10/2011

LOUISVILLE, Colo., May 10, 2011 /PRNewswire/ -- New York City Health and Hospitals Corporation (HHC) and GHX were named to the Supply & Demand Chain Executive 100 for a joint project that helped transform HHC's supply chain into a strategic asset. This year's list, "100 Great Supply Chain Projects," highlights supply chain transformation projects that have produced exceptional business results for an enabler's client.

Three years ago, HHC faced a billion-dollar deficit and a 1.4 million patient population that was heavily reliant on the city hospital system. With an estimated $350 million annual spend for medical-surgical supplies, HHC's supply chain presented a key opportunity for savings to help close its budget gap. However, with a manual procure-to-pay process, the organization needed a more efficient and effective way to gain visibility into what it was spending and a stronger capability to use that visibility to better control spend to achieve its savings objectives.

"In this era of industry reform, healthcare trading partners have been compelled to view the business of healthcare in a completely different light," said GHX CEO Bruce Johnson. "Where the supply chain was once an obscure area of operations hidden from senior leadership, it is fast becoming a focal point for leading healthcare organizations, such as HHC. At GHX, we are working hand in hand with our clients to transform how they conduct business in this new environment, enabling them to cut costs, reduce waste and secure the long-term financial viability of their organizations."

HHC engaged GHX's Consulting Group, Business Solutions, to assess its supply chain, identify the break points and construct new processes, policies and procedures across its procure-to-pay footprint that would help enable the organization to maximize savings and reduce waste. HHC first automated its procure-to-pay process by employing e-commerce with nearly 400 trading partners thr
'/>"/>

SOURCE GHX
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients
2. Joint Commission Urges Patients to Speak Up About Pain
3. Novexel to Present Five Posters at the Joint Annual Interscience Conference on Antimicrobial Agents and Chemotherapy and the Infectious Disease Society of America (ICAAC/IDSA) Meeting
4. New Study Demonstrated ACTEMRA(R) (tocilizumab) Inhibited Progression of Joint Damage in Rheumatoid Arthritis Patients
5. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting
6. Texas Back Institute Leads Way in New Facet Joint Clinical Trial
7. AstraZeneca Responds to FDA Joint Advisory Committees Recommendation on SYMBICORT(R)
8. Orthopaedic Surgeon Shortage Predicted Due to Soaring Joint Replacement Procedures
9. When to Have That Joint Replacement?
10. Beating Blood Clots after Joint Replacement
11. Octogenarians: Not Too Old for Joint Replacement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Calif. , Aug. 31, 2015 ... flow cytometry is experiencing a rise in active ... demand in underdeveloped nations to quantitate CD4 cell ... Logo - http://photos.prnewswire.com/prnh/20150831/262206LOGO ... of the Global Flow Cytometry Market ( http://www.frost.com/nf0e ...
(Date:8/31/2015)... , Aug. 31, 2015  The departments of Drug ... today at Gaudenzia Concept 90 to raise awareness for ... crisis in Pennsylvania and help ... focus on recovery through the Building Bridges to ... are dying every day to a disease that is ...
(Date:8/31/2015)... , Aug. 31, 2015  Diplomat Pharmacy, Inc. (NYSE: ... that Phil Hagerman , Chairman & CEO, and ... conferences. Mr. Hagerman and Mr. Whelan are ... in Boston on Wednesday, September 9, ... Mr. Whelan are also scheduled to participate in the Robert ...
Breaking Medicine Technology:Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 2Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 3Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 4Pennsylvania Departments of Drug & Alcohol Programs and Health Kick-off Second Annual Building Bridges to Recovery Initiative 2Diplomat to Participate in Upcoming Investor Conferences 2
... OrbusNeich today announced that six-month clinical follow-up data show the safety ... balloon (Sequent Please®, B.Braun) followed by implantation of the company,s Genous ... , , , ... investigator-initiated, single center, all-comers POTENT ( P aclitaxel-eluting ball O on ...
... Pfizer Inc. (NYSE: PFE ) announced today that based ... be discontinuing commercial availability of Mylotarg® (gemtuzumab ozogamicin for Injection) (used for ... States and that it will be voluntarily withdrawing the new drug ... , , ...
Cached Medicine Technology:Data Show OrbusNeich's Genous™ Bio-engineered R stent™ is Safe and Effective in Combination with Drug-Eluting Balloon 2Data Show OrbusNeich's Genous™ Bio-engineered R stent™ is Safe and Effective in Combination with Drug-Eluting Balloon 3Pfizer Prepares for Voluntary Withdrawal of U.S. New Drug Application and for Discontinuation of Commercial Availability of Mylotarg® 2Pfizer Prepares for Voluntary Withdrawal of U.S. New Drug Application and for Discontinuation of Commercial Availability of Mylotarg® 3Pfizer Prepares for Voluntary Withdrawal of U.S. New Drug Application and for Discontinuation of Commercial Availability of Mylotarg® 4Pfizer Prepares for Voluntary Withdrawal of U.S. New Drug Application and for Discontinuation of Commercial Availability of Mylotarg® 5Pfizer Prepares for Voluntary Withdrawal of U.S. New Drug Application and for Discontinuation of Commercial Availability of Mylotarg® 6
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... In an ... from the Plastic and Reconstructive Surgery Global Open Journal that discusses the future of ... article discussed how, in the future, customized implants, prosthetics, and other 3-D printed tools ...
(Date:8/31/2015)... ... August 31, 2015 , ... David L. Chalnick, M.D., ... of the first doctors in the area to perform minimally invasive hip replacement ... impressive: faster recovery, decreased immediate and long-term pain, and an accelerated return to ...
(Date:8/31/2015)... Scotch Plains, NJ (PRWEB) , ... August 31, 2015 , ... ... years as an “NJ Top Doc.” , At OSSMC, Dr. Kovatis treats all surgical ... general orthopedics and traumatic injuries to the entire musculoskeletal system, excluding the spine. , ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... diagnostic services, and others—to hold down costs? , In a commentary for ... of HealthReveal, presents the concept of “clinical efficacy,” which would bind parties together ...
(Date:8/31/2015)... CA (PRWEB) , ... August 31, 2015 , ... ... the 2015 ABBY Awards, at the 16th Innovations in Healthcare(SM) Awards Event ... Adaptive Business Leaders (ABL) Organization , recognizes innovative organizations and individuals who ...
Breaking Medicine News(10 mins):Health News:Recent Article on 3-D Printing Highlights the Future of Custom Medical Solutions Using the Technology, says Beverly Hills Physicians 2Health News:Recent Article on 3-D Printing Highlights the Future of Custom Medical Solutions Using the Technology, says Beverly Hills Physicians 3Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 2Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 3Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 4Health News:NJ Top Docs Presents, Dr. Paul Kovatis of Orthopedic Spine & Sports Medicine Center on his Five Year Anniversary as an "NJ Top Doc" 2Health News:How “Clinical Efficacy” Can Rein in Healthcare Costs 2Health News:How “Clinical Efficacy” Can Rein in Healthcare Costs 3Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 2Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 3Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 4Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 5Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 6Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 7Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 8
... 2 Rochester Medical Corporation (Nasdaq: ROCM ) ... 31, 2008.The Company reported sales of $8,436,000 for the current ... year. It also reported net income of $54,000 or ... or $.02 per diluted share for the first quarter of ...
... Calif., Feb. 2 Digirad Corporation (Nasdaq: ... and personnel and equipment leasing services that improve patient ... it has sold the assets related to three northern ... with Rancho Santa Fe, Calif.-based MD Office Solutions calls ...
... More exposure meant more symptoms, study found , , MONDAY, ... hours watching television are at higher risk for depression ... significantly greater odds of being depressed seven years later, ... television viewed, according to a report involving more than ...
... for Quality,Assurance (NCQA) has awarded Unison Health Plan of ... program through December 2011. The plan serves,more than ... is based on how well a health plan ensures ... the health,plan,s core systems and processes, but also the ...
... are heavy users of marijuana are more likely ... to a new study. Pediatric researchers found abnormalities ... regions involved in memory, attention, decision-making, language and ... concern because adolescence is a crucial period for ...
... Post-Katrina flooded homes may contain harmful levels of ... mold films, and aerosols may also have exposed residents, ... without the need for direct skin contact, according to ... (Volume 26, Number 3) of Environmental Engineering Science, a ...
Cached Medicine News:Health News:Rochester Medical Reports First Quarter Results 2Health News:Rochester Medical Reports First Quarter Results 3Health News:Rochester Medical Reports First Quarter Results 4Health News:Rochester Medical Reports First Quarter Results 5Health News:Rochester Medical Reports First Quarter Results 6Health News:Rochester Medical Reports First Quarter Results 7Health News:Rochester Medical Reports First Quarter Results 8Health News:Digirad Corporation Sells Northern California Service Hubs 2Health News:Teen TV Time Tied to Adult Depression 2Health News:Teen TV Time Tied to Adult Depression 3Health News:Unison Health Plan of Ohio Accredited by NCQA 2Health News:Heavy marijuana use may damage developing brain in teens, young adults 2Health News:Newly Described Contaminant Sources in Katrina-Flooded Homes Pose Health Risks 2
... When myocardial infarction is suspected, ... sensitive rapid assay allows rapid ... troponin T from a single ... result is available within minutes ...
The Polygraf ID multi-parametric recorder works with POLYGRAM NET analysis software to create a unique interface that combines web-style navigation, graphical presentation and intuitive design to del...
... the industry standard high intensity 300 Watt Xenon ... price. A universal turret on the front panel ... Olympus, Storz, ACMI/Circon and Wolf cable connectors., ,Front ... timer. The White Sun will quickly illuminate at ...
... is intended for determination of human NGAL ... tissue extracts or culture media., NGAL (neutrophil ... urine, as early as 2 hours after ... processes. NGAL expression in plasma or urine ...
Medicine Products: